• 1
    Melton LJ III. Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res. 2003; 18: 11391141.
  • 2
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359: 17611767.
  • 3
    Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int, 2000; 11: 556561.
  • 4
    Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a worldwide projection. Osteoporos Int. 1992; 2: 285289.
  • 5
    Fleurence RL, Iglesias CP, Torgerson DJ. Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature. Osteoporos Int. 2006; 17: 2940.
  • 6
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007; 22: 465475.
  • 7
    Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003; 1: 7885.
  • 8
    Yoshikawa T, Turner CH, Peacock M, et al. Geometric structure of the femoral neck measured using dual-energy X-ray absorptiometry. J Bone Miner Res. 1994; 9: 10531064.
  • 9
    Cheng XG, Lowet G, Boonen S, et al. Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone. 1997; 20: 213218.
  • 10
    Pulkkinen P, Partanen J, Jalovaara P, Jamsa T. Combination of bone mineral density and upper femur geometry improves the prediction of hip fracture. Osteoporos Int. 2004; 15: 274280.
  • 11
    Crabtree NJ, Kroger H, Martin A, et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The European Prospective Osteoporosis Study. Osteoporos Int. 2002; 13: 4854.
  • 12
    Kaptoge S, Beck TJ, Reeve J, et al. Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res. 2008; 23: 18921904.
  • 13
    Shen H, Long JR, Xiong DH, et al. Mapping quantitative trait loci for cross-sectional geometry at the femoral neck. J Bone Miner Res. 2005; 20: 19731982 .
  • 14
    Slemenda CW, Turner CH, Peacock M, et al. The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos Int. 1996; 6: 178182.
  • 15
    Demissie S, Dupuis J, Cupples LA, Beck TJ, Kiel DP, Karasik D. Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study. Bone. 2007; 40: 743750.
  • 16
    Xiong DH, Shen H, Xiao P, et al. Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J Bone Miner Res. 2006; 21: 424437.
  • 17
    Qureshi AM, McGuigan FE, Seymour DG, Hutchison JD, Reid DM, Ralston SH. Association between COLIA1 Sp1 alleles and femoral neck geometry. Calcif Tissue Int. 2001; 69: 6772.
  • 18
    Jiang H, Lei SF, Xiao SM, et al. Association and linkage analysis of COL1A1 and AHSG gene polymorphisms with femoral neck bone geometric parameters in both Caucasian and Chinese nuclear families. Acta Pharmacol Singapore. 2007; 28: 375381.
  • 19
    Xiong DH, Liu YZ, Liu PY, Zhao LJ, Deng HW. Association analysis of estrogen receptor alpha gene polymorphisms with cross-sectional geometry of the femoral neck in Caucasian nuclear families. Osteoporos Int. 2005; 16: 21132122.
  • 20
    Moffett SP, Zmuda JM, Oakley JI, et al. Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab, 2005; 90: 34913497.
  • 21
    Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, et al. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res. 2004; 19: 12801290.
  • 22
    McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges: genome-wide association studies in alzheimer disease. Nat Rev Genet. 2008; 9: 356369.
  • 23
    Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005; 6: 95108.
  • 24
    Hu N, Wang C, Hu Y, et al. Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res. 2005; 65: 25422546.
  • 25
    Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007; 8: 657662.
  • 26
    Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 13411345.
  • 27
    Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3: e115.
  • 28
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358: 23552365.
  • 29
    Richards JB, Rivadeneira F, Inouye M, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371: 15051512.
  • 30
    Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet. 2007; 8: S14.
  • 31
    Duan Y, Beck TJ, Wang XF, Seeman E. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res. 2003; 18: 17661774.
  • 32
    Beck TJ. Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos Int. 2003; 14: S81S88.
  • 33
    Di X, Matsuzaki H, Webster TA, et al. Dynamic model based algorithms for screening and genotyping over 100K SNPs on oligonucleotide microarrays. Bioinformatics. 2005; 21: 19581963 .
  • 34
    Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics. 2006; 22: 712.
  • 35
    Dixon SC, Horti J, Guo Y, Reed E, Figg WD. Methods for extracting and amplifying genomic DNA isolated from frozen serum. Nat Biotechnol. 1998; 16: 9194.
  • 36
    Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38: 904909.
  • 37
    Lencz T, Morgan TV, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry. 2007; 12: 572580.
  • 38
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263265.
  • 39
    Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004; 74: 765769.
  • 40
    Fisher RA. Statistical methods for research workers, 14th ed. New York: Hafner, 1970. (Originally Published: Edinburg: Oliver and Boyd, 1925.)
  • 41
    Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000; 155: 945959.
  • 42
    Filardi S, Zebaze RM, Duan Y, Edmonds J, Beck T, Seeman E. Femoral neck fragility in women has its structural and biomechanical basis established by periosteal modeling during growth and endocortical remodeling during aging. Osteoporos Int. 2004; 15: 103107.
  • 43
    Beck TJ, Stone KL, Oreskovic TL, et al. Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the Study of Osteoporotic Fractures. J Bone Miner Res. 2001; 16: 21032110.
  • 44
    Beck TJ, Oreskovic TL, Stone KL, et al. Structural adaptation to changing skeletal load in the progression toward hip fragility: the Study of Osteoporotic Fractures. J Bone Miner Res. 2001; 16: 11081119.
  • 45
    Gluer CC, Cummings SR, Pressman A, et al. Prediction of hip fractures from pelvic radiographs: the Study of Osteoporotic Fractures. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1994; 9: 671677.
  • 46
    Partanen J, Jamsa T, Jalovaara P. Influence of the upper femur and pelvic geometry on the risk and type of hip fractures. J Bone Miner Res. 2001; 16: 15401546.
  • 47
    Beck TJ, Ruff CB, Mourtada FA, et al. Dual-energy X-ray absorptiometry derived structural geometry for stress fracture prediction in male US Marine Corps recruits. J Bone Miner Res. 1996; 11: 645653.
  • 48
    Ruff CB. Body size, body shape, and long bone strength in modern humans. J Hum Evol. 2000; 38: 269290.
  • 49
    Ioannidis JP, Ng MY, Sham PC, et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res. 2007; 22: 173183.
  • 50
    Duncan EL, Brown MA, Sinsheimer J, et al. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res. 1999; 14: 19931999 .
  • 51
    Xiao P, Shen H, Guo YF, et al. Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res. 2006; 21: 15361544.
  • 52
    Wilson SG, Reed PW, Bansal A, et al. Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet. 2003; 72: 144155.
  • 53
    Benes H, Weinstein RS, Zheng W, et al. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res. 2000; 15: 626633.
  • 54
    Liu YZ, Wilson SG, Wang L, et al. Identification of PLCL1 gene for hip bone size variation in females in a genome-wide association study. PLoS ONE. 2008; 3: e3160.
  • 55
    Kiss H, Darai E, Kiss C, et al. Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. Mamm Genome. 2002; 13: 646655.
  • 56
    Kiss H, Yang Y, Kiss C, et al. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. Eur J Hum Genet. 2002; 10: 5261.
  • 57
    Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G, Imreh S. Downregulation of 3p genes, LTF, SLC38A3, and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer. 2006; 119: 99107.
  • 58
    Saito H, Kubota M, Roberts RW, Chi Q, Matsunami H. RTP family members induce functional expression of mammalian odorant receptors. Cell. 2004; 119: 679691.
  • 59
    Sorio C, Capelli P, Lissandrini D, et al. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion. Virchows Arch. 2005; 446: 239245.
  • 60
    Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer 2003; 2: 7.
  • 61
    Tannapfel A, Anhalt K, Hausermann P, et al. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol. 2003; 201: 238249.
  • 62
    Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol. 2003; 200: 3946.
  • 63
    Wu L, Wu Y, Gathings B, et al. Smad4 as a transcription corepressor for estrogen receptor alpha. J Biol Chem. 2003; 278: 1519215200.
  • 64
    Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem. 2001; 276: 4290842914.
  • 65
    Yamamoto T, Saatcioglu F, Matsuda T. Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology. 2002; 143: 26352642.
  • 66
    Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF-β, and BMP. Bone. 1996; 19: 1S12S.
  • 67
    Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002; 23: 279302.
  • 68
    Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath T, Ten DP. Localization of Smads, the TGF-β family intracellular signaling components during endochondral ossification. J Bone Miner Res. 1999; 14: 11451152.
  • 69
    Zhang J, Tan X, Li W, et al. Smad4 is required for the normal organization of the cartilage growth plate. Dev Biol. 2005; 284: 311322.
  • 70
    Yu Y, Bliss JP, Bruce WJ, Walsh WR. Bone morphogenetic proteins and Smad expression in ovine tendon-bone healing. Arthroscopy. 2007; 23: 205210.
  • 71
    Farhadieh RD, Gianoutsos MP, Yu Y, Walsh WR. The role of bone morphogenetic proteins BMP-2 and BMP-4 and their related postreceptor signaling system (Smads) in distraction osteogenesis of the mandible. J Craniofac Surg. 2004; 15: 714718.
  • 72
    Alvarez J, Serra R. Unique and redundant roles of Smad3 in TGF-β-mediated regulation of long bone development in organ culture. Dev Dyn. 2004; 230: 685699.
  • 73
    Luciano M, Lind PA, Deary IJ, et al. Testing replication of a 5-SNP set for general cognitive ability in six population samples. Eur J Hum Genet. 2008; 16: 1025.
  • 74
    Houlston RS, Webb E, Broderick P, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008; 40: 14261435.
  • 75
    Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638645.
  • 76
    Beck TJ, Ruff CB, Warden KE, Scott WW Jr, Rao GU. Predicting femoral neck strength from bone mineral data: a structural approach. Invest Radiol. 1990; 25: 618.